Stem Cell Therapy For Acute Ischemic Stroke Patients "InVeST"


Phase 2 Results N/A

Summary of Purpose

The purpose of this study is to determine whether patients with subacute ischemic stroke will benefit from infusion of patient's own bone marrow derived stem cells. Primary Hypothesis: Intravenous injection of bone marrow mononuclear cells at a dose of 30 to 500 million in patients with subacute ischemic stroke results in reduction of infarct volume and improvement of neurological function compared to those...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 April 2015.

1 Jan 2009 7 Apr 2015 1 Oct 2010 1 Jun 2011 1 Apr 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


Not available